Neuropediatrics · 2018 · 28 citations · 5 references
Life SciencesGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsNeurodegenerationGenetic DisordersGenetic EpilepsiesMolecular Basis Of NeurodegenerationNeurodegenerative DiseasesNeurodegenerative DisordersNeurogenetic DisordersDrug-resistant Epilepsy GeneticsExome SequencingGenetic NeurodegenerationHereditary EpilepsiesLanguage RegressionPathogenic Variant AssociationPediatric Drug-resistant EpilepsyRecurrent Pathogenic Variants
Introduction Neurodegenerative diseases of childhood present with progressive decline in cognitive, social, and motor function and are frequently associated with seizures in different stages of the disease. Here we report a patient with severe progressive neurodegeneration with drug-resistant epilepsy of unknown etiology from the age of 2 years. Methods and Results Using whole exome sequencing, we found heterozygous missense de novo variant c.628G > A (p.Glu210Lys) in the UBTF gene. This variant was recently described as de novo in 11 patients with similar neurodegeneration characterized by developmental decline initially confined to motor development followed by language regression, appearance of an extrapyramidal movement disorder, and leading to severe intellectual disability. In 3 of the 11 patients described so far, seizures were also present. Conclusions Our report expands the complex phenotype of neurodegeneration associated with the c.628G > A variant in the UBTF gene and helps to clarify the relation between this one single recurrent pathogenic variant described in this gene to date and its phenotype. The UBTF gene should be considered a novel candidate gene in neurodegeneration with or without epilepsy.
5
DeNovoGear: de novo indel and point mutation discovery and phasing
Avinash Ramu, Michiel J. Noordam, Rachel S. Schwartz et al. · Nature Methods · 2013 · 195 citations · Full text
David Staněk, Petra Laššuthová, Katalin Štěrbová et al. · Orphanet Journal of Rare Diseases · 2018 · 26 citations · Full text